Gabriele Lo Buglio1‡
Tommaso Boldrini2*‡
Andrea Polari3,4‡
Flavia Fiorentino1‡
Barnaby Nelson4,5‡
Marco Solmi6,7,8,9,10‡
Vittorio Lingiardi1†‡
Annalisa Tanzilli1†‡- 1Department of Dynamic and Clinical Psychology, and Health Studies, Faculty of Medicine and Psychology, Sapienza University of Rome, Rome, Italy
- 2Department of Psychology and Educational Science, Pegaso Telematic University, Naples, Italy
- 3Orygen Specialist Programs, Melbourne, VIC, Australia
- 4Centre for Youth Mental Health, The University of Melbourne, Parkville, VIC, Australia
- 5Orygen, Parkville, VIC, Australia
- 6Department of Psychiatry, University of Ottawa, Ottawa, ON, Canada
- 7On Track: The Champlain First Episode Psychosis Program, Department of Mental Health, The Ottawa Hospital, Ottawa, ON, Canada
- 8Clinical Epidemiology Program, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada
- 9Faculty of Medicine, School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada
- 10Department of Child and Adolescent Psychiatry, Charité-Universitätsmedizin Berlin, Berlin, Germany
Aims: To map studies assessing both clinical high risk for psychosis (CHR-P) and borderline personality disorder (BPD) in clinical samples, focusing on clinical/research/preventive paradigms and proposing informed research recommendations.
Methods: We conducted a PRISMA-ScR/JBI-compliant scoping review (protocol: https://osf.io/8mz7a) of primary research studies (cross-sectional/longitudinal designs) using valid measures/criteria to assess CHR-P and BPD (threshold/subthreshold) in clinical samples, reporting on CHR-P/psychotic symptoms and personality disorder(s) in the title/abstract/keywords, identified in Web of Science/PubMed/(EBSCO)PsycINFO until 23/08/2023.
Results: 33 studies were included and categorized into four themes reflecting their respective clinical/research/preventive paradigm: (i) BPD as a comorbidity in CHR-P youth (k = 20), emphasizing early detection and intervention in psychosis; (ii) attenuated psychosis syndrome (APS) as a comorbidity among BPD inpatients (k = 2), with a focus on hospitalized adolescents/young adults admitted for non-psychotic mental disorders; (iii) mixed samples (k = 7), including descriptions of early intervention services and referral pathways; (iv) transdiagnostic approaches (k = 4) highlighting “clinical high at risk mental state” (CHARMS) criteria to identify a pluripotent risk state for severe mental disorders.
Conclusion: The scoping review reveals diverse approaches to clinical care for CHR-P and BPD, with no unified treatment strategies. Recommendations for future research should focus on: (i) exploring referral pathways across early intervention clinics to promote timely intervention; (ii) enhancing early detection strategies in innovative settings such as emergency departments; (iii) improving mental health literacy to facilitate help-seeking behaviors; (iv) analysing comorbid disorders as complex systems to better understand and target early psychopathology; (v) investigating prospective risk for BPD; (vi) developing transdiagnostic interventions; (vii) engaging youth with lived experience of comorbidity to gain insight on their subjective experience; (viii) understanding caregiver burden to craft family-focused interventions; (ix) expanding research in underrepresented regions such as Africa and Asia, and; (x) evaluating the cost-effectiveness of early interventions to determine scalability across different countries.
Systematic Review Registration: https://osf.io/8mz7a.
1 Introduction
Adolescence and young adulthood are crucial developmental periods and, given 62.5% of mental disorders have an onset before age 25 (Solmi et al., 2022), are an important setting for the provision of early intervention strategies. These are aimed at preventing the onset of severe mental health conditions and their most adverse outcomes, including reduced life expectancy, disability, and limited academic and work attainments (Fusar-Poli et al., 2021; World Health Organization, 2022). Consistently, within the context of primary indicated prevention, early detection and intervention services have been implemented worldwide for youth manifesting the first signs and symptoms of emerging mental disorders (Shah et al., 2020).
One of the most consolidated preventive paradigms is the “clinical high-risk for psychosis” (CHR-P) paradigm, which focuses on help-seeking youth with sub-threshold psychotic symptoms, functional impairments, and presenting with up to 25% likelihood of developing a first-episode psychosis (FEP) over 3 years (Fusar-Poli et al., 2020a; Salazar de Pablo et al., 2021b). Notably, over three-quarters of CHR-P youth present with comorbid (i.e., co-existing) non-psychotic mental disorders that need clinical attention (Solmi et al., 2023). Among these, one of the most severe and potentially disabling is borderline personality disorder (BPD), which has been observed in 10% of CHR-P cases (Solmi et al., 2023) and displays a pervasive pattern of clinical manifestations, including unstable interpersonal relationships, affective instability, and self-mutilating behaviors (Chanen and Thompson, 2018; American Psychiatric Association, 2022).
Notably, BPD is also a “novel public health priority” (Chanen et al., 2017) and has been the subject of growing clinical and research interest, which has led to a specific early intervention paradigm focusing on young people with BPD and sub-syndromal borderline personality pathology (Chanen and Thompson, 2018). Clinical presentations of BPD patients are complex, and comorbid psychotic symptoms are frequently reported, with 29-50% of BPD cases experiencing auditory hallucinations (Fagioli et al., 2015; Cavelti et al., 2021).
Overall, early intervention paradigms focusing on either CHR-P or BPD show critical differences. For example, early services focusing on CHR-P (e.g., Personal Assessment and Crisis Evaluation; PACE) (Yung et al., 2007) strive to prevent the onset of full-blown psychotic disorders, whereas clinical centers focusing on BPD (e.g., Helping Young People Early; HYPE) (Chanen et al., 2009) seek to assess and address emerging severe personality disorders (PDs).
Although such services have been implemented to meet the clinical needs of different populations, CHR-P and BPD can co-exist. Moreover, they also share crucial outcomes, including high societal costs and long-term risks for self-harm, unemployment, and disability (The Public Health Group, 2005; Chanen, 2017; Fusar-Poli et al., 2020a, 2021).
However, although their co-occurrence is well-established, the consensus on the best clinical pathways for youth with both CHR-P state and BPD–even in attenuated forms–is limited, highlighting crucial shortcomings of current early paradigms. First, international clinical guidelines are specific to CHR-P (NICE, 2014; Schmidt et al., 2015) or BPD (NICE, 2009; Simonsen et al., 2019), with non-exhaustive information on the clinical management of youth with both clinical conditions. Second, treatment clinics for CHR-P and BPD may be separated and disconnected–even geographically–hindering fundamental collaborations among mental health systems and timely intervention. Third, although recent transdiagnostic approaches are promising since they “cut across,” single diagnostic entities, such models still need to be implemented at scale (Shah et al., 2020). Ironically, even though the comorbidity concept can be considered partially artifactual (Nordgaard et al., 2023), the co-existence of CHR-P and borderline personality pathology impacts “tangibly” both referral pathways of young people and decision aids of clinicians operating in mental health services. It is essential to produce research recommendations for future studies that may advance clinical care, also considering the urgent transformation for mental health argued in the recent World Health Organization (WHO) mental health report (World Health Organization, 2022).
Given this background, the current scoping review aims to explore original research on CHR-P state and BPD. This is essential to propose informed research recommendations. A scoping review design was selected (Tricco et al., 2018). In contrast with previous reviews, we do not seek to establish the meta-analytic prevalence of BPD in CHR-P samples (Boldrini et al., 2019; Solmi et al., 2023) nor explore the clinical overlap/relationship between early psychosis and BPD (West et al., 2021; Biancalani et al., 2023); instead, we aim to systematically screen and explore the body of studies including CHR-P and BPD, map clinical/research/preventive paradigms and generate informed research recommendations across preventive paradigms.
1.1 Review questions
(a) Which clinical/research/preventive paradigm, measures, study goals, geographic/temporal distribution, and clinical centers characterize the literature on BPD (threshold and subthreshold) and CHR-P state? (b) What are the clinical recommendations and research challenges according to the authors of relevant studies? (c) Which areas need further investigation?
2 Materials and methods
The proposed scoping review was performed in line with the PRISMA-ScR and JBI methodology for scoping reviews (Peters et al., 2015; Tricco et al., 2018; Peters et al., 2020; Khalil et al., 2021) and previous scoping reviews (Fornaro et al., 2021). See Supplementary material S1. The a-priori protocol was pre-registered in Open Science Framework (OSF: https://osf.io/8mz7a). Deviations from the original protocol are reported in the Supplementary material S2.
2.1 Inclusion/exclusion criteria
Included were: (a) primary research studies (i.e., “standard” research articles, letters to the Editor, brief reports, single cases, conference abstracts and, in general, “grey literature”) with any study design (e.g., randomized controlled trials, observational studies, cross-sectional and longitudinal studies), (b) focusing on clinical samples (“Population”), (c) using valid and reliable measures or diagnostic criteria to assess both BPD/BPD symptoms and CHR-P state/attenuated psychosis syndrome (APS) (“Concept”), (d) reporting information on at-risk state (or psychotic symptoms) and PDs or personality pathology (schizotypal personality disorder excluded since it is part of CHR-P inclusion criteria) in the title and/or abstract and/or keywords, and (e) written in English.
Excluded were: (a) reviews, (b) studies not focusing on clinical samples (e.g., general population), (c) not written in English. No restrictions were applied on context or geographical location (“Context”). Potential overlap among samples was not an exclusion criterion since this scoping review aimed to gather any relevant primary research study to map conceptualizations of clinical care/services, emphasizing the clinical/research “lens” adopted by the authors of each relevant study.
2.2 Search strategy
The search strategy aimed to identify both published and unpublished studies. A first limited search of PubMed, EBSCO/PsycINFO, and Web of Science was conducted by GLB. The initial search results were shared and discussed with the other authors of the current study. The text words contained in the titles and abstracts of relevant studies and the index terms (plus other words related to the topic of the current scoping review) were employed to develop a full search strategy for PubMed, Web of Science, and EBSCO/PsycINFO (see Supplementary material S3). The reference list of the included studies was screened for additional studies. Finally, further studies were searched on ResearchGate. A multi-step literature search was performed on Pubmed, Web of Science, and EBSCO/PsycINFO for studies published from inception to the 23rd August 2023. Citations were uploaded into Mendeley Manager/Mendeley Desktop, and duplicates were automatically excluded. GLB and a supervised student (see “Acknowledgments”) independently conducted the screening. First, titles and abstracts were checked, and then the full texts were examined. Reasons for exclusion at the full-text level were recorded. Disagreements were solved by contacting a third judge (AT).
2.3 Data extraction
Data were extracted by GLB. The data extracted on the characteristics of the studies was checked by FF. The following were extracted: (a) Country, sample (N, mean age, sex), type of publication (i.e., peer-review journal, grey literature, book), year, study design, and study goals; (b) Measures employed to assess BPD and CHR-P; (c) Information on other (non-borderline) PDs; (d) Research recommendations of authors of included studies; (e) Clinical recommendations of authors of included studies; (f) Concepts regarding early intervention services and early intervention strategies; (g) Potential other relevant concepts were detected, and research gaps were highlighted.
The.xls data charting file was updated while extracting the data. Potential disagreements among the authors were solved via discussion. Authors of included articles were contacted for missing or additional information.
2.4 Data analysis and presentation
We presented the findings in a narrative synthesis and one table and organized them into major concepts identified across the included studies. To answer the review questions (a) and (b), we organized the included studies and their data into four major concepts reflecting different clinical or research paradigms: BPD as a comorbidity among CHR-P youth (k = 20); attenuated psychosis syndrome (APS) as a comorbidity among BPD inpatients (k = 2); mixed samples (k = 7); transdiagnostic approaches (k = 4). Ten research recommendations beyond diagnostic silos were finally proposed. The results were discussed in the context of international guidelines (NICE, 2009, 2014; Schmidt et al., 2015; Simonsen et al., 2019) and the recent WHO mental health report (World Health Organization, 2022).
3 Results
3.1 Study selection
972 studies were detected across registries and databases, 322 of which were duplicates, and 9 records were identified via other methods (Figure 1). 585 studies were excluded at the title-abstract level, and 41 were excluded after examining the full-texts. Reasons for exclusion at the full-text level are reported in the Supplementary material S4. We ultimately included 33 studies, and their main characteristics are displayed in Table 1. A total of 14 studies were conducted in clinical centers located in Europe, 10 in Australia, 7 in the US, and 2 studies in multiple countries. Included studies were published between 2012 and 2023, with the latter being the year with the most studies (k = 5). Overall, 25 publications were standard research articles, 2 were conference abstracts/conference papers, 2 were dissertations, 2 were brief reports, and 2 were Letters to the Editor. 15 studies were cross-sectional, 13 were cohort studies, and 5 were case–control studies.
Figure 1. The PRISMA-ScR flow diagram of the literature search and the selection process.
Table 1. Characteristics of the included studies.
3.2 BPD as a comorbidity among CHR-P youth
20 studies (Schultze-Lutter et al., 2012; Thompson et al., 2012; Byars, 2013; Nelson et al., 2013; Barrantes-Vidal et al., 2014; Rutigliano et al., 2016; Fusar-Poli et al., 2017; Ryan et al., 2017; Kotlicka-Antczak et al., 2018; Madsen et al., 2018; Sevilla-Llewellyn-Jones et al., 2018; O’Connor et al., 2019; Paust et al., 2019; Hadar et al., 2020; Boldrini et al., 2020b; DaBreo-Otero, 2021; West et al., 2022; Ceccolini et al., 2023; Pelizza et al., 2023; Tronick et al., 2023) focused on early detection and intervention within the framework of the CHR-P paradigm. Overall, the clinical population comprised CHR-P patients and, in some studies, control patients, accessing CHR-P clinics or mental health services. CHR-P patients reported a range of comorbid mental disorders, including BPD. The studies’ goals and the clinical and research recommendations of the study authors did not focus solely on BPD, encompassing a range of clinical and research issues in the clinical management of CHR-P patients.
Specifically, clinical recommendations included evaluating at-risk mental state in samples enriched (Fusar-Poli et al., 2017), adopting clinician report measures to assess PDs (Boldrini et al., 2020b), and monitoring comorbid mental health conditions over time (Byars, 2013; Rutigliano et al., 2016; Madsen et al., 2018; Sevilla-Llewellyn-Jones et al., 2018), including BPD (Ryan et al., 2017; DaBreo-Otero, 2021) to deliver appropriate intervention (Paust et al., 2019). Other authors highlighted the role of assessing perceptual abnormalities (O’Connor et al., 2019), disturbances at different levels of selfhood (Nelson et al., 2013), and childhood trauma (Barrantes-Vidal et al., 2014; O’Connor et al., 2019) in CHR-P samples. Pelizza et al. (2023) highlighted the need to overcome the barriers between adult and child/adolescent mental health services, reduce antipsychotic dosage and delivering psychosocial interventions, and establish cultural mediation services within early intervention clinics. Other clinical recommendations included providing non-stigmatizing settings (Kotlicka-Antczak et al., 2018), fostering protective factors [e.g., social support Tronick et al., 2023], planning psychological treatments focused on underlying personality traits (Schultze-Lutter et al., 2012), and improving non-psychotic disorders and general functioning beyond preventive aims (Rutigliano et al., 2016).
Research recommendations within the CHR-P framework included developing and test new early intervention strategies for comorbid PDs, including BPD (Schultze-Lutter et al., 2012), assessing personality and/or trauma in intervention studies (Thompson et al., 2012; Hadar et al., 2020; Boldrini et al., 2020b), and investigating outcomes other than conversion to psychosis (e.g., development of non-psychotic mental disorders) (Rutigliano et al., 2016) in comparison with healthy controls (Fusar-Poli et al., 2017). West et al. (2022) emphasized research into the antecedents of symptoms. One study suggested investigating self-disturbances–for details, (see Henriksen et al., 2021)–to improve the (challenging) differential diagnosis between borderline personality pathology and schizophrenia spectrum disorders (Nelson et al., 2013; Ryan et al., 2017). Research efforts with larger samples (Sevilla-Llewellyn-Jones et al., 2018; Paust et al., 2019) and longitudinal study designs (Thompson et al., 2012; Rutigliano et al., 2016; O’Connor et al., 2019) were recommended, and the need to provide more understanding and further treatment options was emphasized (Madsen et al., 2018).
3.3 APS as a comorbidity among BPD inpatients
2 studies (Gerstenberg et al., 2015; Salazar de Pablo et al., 2020b) focused on patients with a wide range of mental health conditions, including BPD, with or without APS. Specifically, samples from both studies were composed of inpatient (hospitalized) adolescents or young adults admitted for non-psychotic mental disorders at the Child and Adolescent Inpatient Unit of the Zucker Hillside Hospital, New York.
Clinical recommendations in APS adolescents included age-sensitive “staged” intervention models (Gerstenberg et al., 2015). Moreover, targeting poor stress tolerance and perceptual abnormalities in need-based interventions was suggested to foster quality of life and reduce the burden experienced by both patients and their families (Salazar de Pablo et al., 2020b).
Research recommendations of Salazar De Pablo et al. (2020b) included investigating comorbid mental health conditions in APS and their relevance for the risk of developing psychosis–especially in adolescents–while Gerstenberg et al. (2015) emphasized the need for long-term prospective studies with large samples to illuminate APS and its frequency, associated characteristics, evolution from childhood to adulthood, and long-term outcomes.
3.4 Mixed samples
7 studies (Koutsouleris et al., 2014; McMillan et al., 2017; Sanchez et al., 2019; Seiler et al., 2020; Burke et al., 2022; Gajwani et al., 2022; Gruber et al., 2023) included patients at CHR-P and patients with BPD, with or without additional samples of patients with FEP or major depressive disorder/mood disorders and healthy controls. In this theme, CHR-P and BPD represented different clinical populations (even though some CHR-P youth also displayed a comorbid BPD). Four studies focused on Youth Mental Health Services in Melbourne, which provided descriptions of preventive services for adolescents and young adults, including HYPE (for BPD), PACE (for CHR-P), and additional early clinics for mood disorders and FEP. These studies also delivered information about referral pathways (McMillan et al., 2017; Sanchez et al., 2019; Seiler et al., 2020; Burke et al., 2022).
Clinical recommendations included assessing sub-threshold positive symptoms in help-seeking youth even though their major complaint is non-psychotic (Seiler et al., 2020), screening for neurodevelopmental disorders and adverse childhood experiences (Gajwani et al., 2022), integrating sexual health screening into initial assessment (Sanchez et al., 2019), and implementing a range of strategies to address sexual health and sexual dysfunction (McMillan et al., 2017). Gruber et al. emphasized the clinical implications of comprehensive assessment measures to evaluate identity- and self-disturbances (Gruber et al., 2023). Burke et al. (2022) argued that early intervention clinics may work alongside so-called “public health approaches”–for details, (see Ajnakina et al., 2019)–to lower the exposure to environmental factors (e.g., cannabis) associated with an increased risk for psychosis. However, other methods are needed to detect more cases at risk for psychosis. For example, youth reaching emergency departments with self-harm may be targeted by early clinics since they appear to be at increased risk for psychosis–for details, see Bolhuis (2021).
Research recommendations included employing longitudinal study designs (Gajwani et al., 2022; Gruber et al., 2023), investigating more specific neuroanatomical biomarkers (Koutsouleris et al., 2014), and replicating relevant study findings. For example, Burke et al. (2022) showed fewer voluntary and involuntary hospital admissions in youth who had transitioned to psychosis from PACE, HYPE, or primary care compared to cases presenting directly with FEP. Other authors highlighted the need for clinical pathways to address sexual health and sexual dysfunction in youth with mental health conditions (McMillan et al., 2017; Sanchez et al., 2019).
3.5 Transdiagnostic approaches
4 studies (Agius et al., 2013; Hartmann et al., 2021; Monego et al., 2022; Destrée et al., 2023) adopted a transdiagnostic approach, 3 of which (Hartmann et al., 2021; Monego et al., 2022; Destrée et al., 2023) applied the recent “clinical high at risk mental state” (CHARMS) criteria, which identify potentially (partially) overlapping at-risk states for psychosis, BPD, mania/bipolar disorder, and severe depressive disorder. Essential concepts are the “clinical staging” model and “pluripotency.” While the former refers to a dimensional approach that collocates the person in a continuum from an asymptomatic state to chronic and disabling conditions, the latter refers to an agnostic stance about the trajectory of mental disorders (i.e., multiple outcomes are possible) (Hartmann et al., 2021). CHARMS approach aims to capture both “homotypic progression” (e.g., an individual at CHR-P goes on to develop FEP) and “heterotypic progression” (e.g., an individual with sub-syndromal borderline personality pathology goes on to develop a major depressive disorder) (Hartmann et al., 2021).
Before developing CHARMS criteria, Agius et al. (2013) recommended using the CAARMS to assess difficult patients. Overall, an overarching goal of transdiagnostic approaches is to “maximize clinical utility” (Hartmann et al., 2021). Accordingly, research recommendations included broadening CHARMS criteria (e.g., by including also eating disorders and obsessive-compulsive disorder) (Hartmann et al., 2021), exploring conversion to different mental health conditions of each CHARMS group and their overlaps, investigating the role of transdiagnostic or specific symptoms at intake and functioning in predicting CHARMS exit mental health conditions (Monego et al., 2022), and adopting more dynamic research approaches (Hartmann et al., 2021). Finally, Destrée et al. suggested exploring the relationship between specific stressful experiences and obsessive-compulsive dimensions (Destrée et al., 2023).
4 Discussion
The current scoping review revealed heterogeneous clinical paradigms. Specifically, the included studies were organized into four major themes: BPD as a comorbidity among CHR-P youth, APS as a comorbidity among BPD inpatients, mixed samples, and transdiagnostic approaches. Notably, high heterogeneity was observed both across themes and within each theme. Finally, research recommendations beyond diagnostic silos were proposed.
The core finding of this scoping review is that young people with CHR-P/APS and/or BPD may be subject to a range of clinical and research paradigms. For example, BPD can be considered a comorbid mental disorder in CHR-P/APS patients that needs to be assessed and treated. Moreover, CHR-P and BPD can also represent admission diagnoses to diverse early clinics. Finally, sub-threshold psychotic symptoms and sub-threshold BPD can both be part of broader transdiagnostic approaches.
Overall, no clear therapeutic approaches have been developed for people presenting with both conditions. There is some evidence of therapeutic modalities either for BPD or CHR-P but not for both. Also, the targets of the intervention are different, with mainly transition to psychosis in CHR-P population and social and vocational functioning in BPD clinics.
Notably, the differential diagnosis is challenging since key features of a BPD diagnosis (e.g., “unstable self-image or sense of self” and experiencing “chronic feelings of emptiness”) have been consistently reported in literature focusing on schizophrenia spectrum disorders (Lingiardi, 2019; Zandersen and Parnas, 2019). This has crucial implications since patients may receive diverse treatments in highly specialized services based on diagnosis (Zandersen et al., 2019; Zandersen and Parnas, 2020).
This large body of topics and clinical and research recommendations identified in the first theme (BPD as a comorbidity among CHR-P youth) indirectly corroborates the heterogeneity of the CHR-P population observed in previous meta-research in terms of clinical presentation, clinical correlates, clinical services, and long-term outcomes (Beck et al., 2019; Fusar-Poli et al., 2020a; Catalan et al., 2021; Salazar de Pablo et al., 2021b, 2021a; Bargiota et al., 2023; Solmi et al., 2023). The second theme (APS as a comorbidity among BPD inpatients) and the fourth theme (transdiagnostic approaches) reflect a growing clinical and research interest in APS (Salazar de Pablo et al., 2020a) and transdiagnostic frameworks (Shah et al., 2020; Uhlhaas et al., 2023), respectively. Finally, some studies in the third theme (mixed samples) suggested the benefits of accessing early services before developing psychosis (e.g., reduced hospitalizations) (Burke et al., 2022), providing details into youth mental health services, entry points for potential clients, and pathways of referral to specialist clinics.
4.1 Research recommendations
Despite the growing body of research, early approaches are hindered by shortcomings that need to be addressed by future empirical investigations. Accordingly, we proposed 10 research recommendations (Table 2) generated by harmonizing our scoping review results with current research gaps, clinical guidelines (NICE, 2009, 2014; Schmidt et al., 2015; Simonsen et al., 2019), and the recent WHO mental health report (World Health Organization, 2022).
Table 2. Research recommendations.
First, little research has focused on referral pathways of young people at risk of developing severe mental disorders. Research efforts in this field may advance coordination among different clinical services and different clinical paradigms, promoting timely intervention and appropriate referrals for each patient profile.
Second, international recommendations aim to keep the duration of untreated psychosis (i.e., the timing between the first symptom and initiation of adequate intervention) (Marshall et al., 2005) below 3 months (Bertolote and McGorry, 2005), given its prognostic significance (Howes et al., 2021). Developing early detection strategies in innovative clinical settings–e.g., emergency departments (Solmi et al., 2020)–might improve timely referral to appropriate care, reducing the duration of untreated symptoms.
Third, early clinics may be actively involved in developing programs to improve the so-called “mental health literacy” (i.e., “the ability to recognize and possess knowledge of a variety of different profiles of emerging and established mental disorders […]”) (Fusar-Poli et al., 2020b) in the general population, thus promoting help-seeking behaviors (Jorm, 2000; Jorm et al., 2006; Altuncu et al., 2023).
Fourth, there is little consensus on the best intervention for CHR-P youth with BPD (or vice-versa). Research efforts conceptualizing comorbid conditions as a complex system (e.g., network analysis) may improve understanding of early psychopathology manifestations and potentially suggest relevant intervention targets (Nelson et al., 2017; Borsboom et al., 2021; Ong et al., 2021; Lo Buglio et al., 2022).
Fifth, further research on the risk of developing psychosis in BPD patients may be crucial to monitor and, ideally, prevent the onset of full-blown psychotic symptoms. Moreover, further research is needed on the onset of diagnosable BPD from sub-syndromal borderline personality pathology.
Sixth, developing transdiagnostic interventions is a growing clinical and research need (Reininghaus et al., 2023).
Seventh, research engaging youth with lived experience of BPD and CHR-P may illuminate their subjective experience–for psychosis, (see Fusar-Poli et al., 2022)–promoting appropriate clinical management (Simonsen et al., 2019; Boldrini et al., 2020a; West et al., 2021).
Eight, caregivers may often need to demonstrate disabling mental health conditions in young people for whom they care to gain the attention of psychiatric services (McGorry et al., 2022). Investigating the burden experienced by caregivers may help develop comprehensive interventions considering the whole family system, further supporting the recovery process in the young person.
Ninth, none of the included studies originated from Asia and Africa, suggesting a need for research in this field across wider geographical regions.
Tenth, further cost-effectiveness research (Aceituno et al., 2019) on early intervention services in multiple countries is crucial to provide robust indications about their feasibility at scale.
4.2 Strengths and limitations
The main strengths of this scoping review include broad inclusion criteria, a systematic study selection process, results focusing on a range of clinical/preventive paradigms, and informed research recommendations toward paradigm integration. This study has several limitations. First, our study design did not allow for the development of clinical guidelines. Nevertheless, our study allowed for generating informed research recommendations since we harmonized findings of this scoping review with research gaps and clinical guidelines. Second, due to multiple clinical and research recommendations in the included studies, we selected and emphasized the most consistent with the aims of this current scoping review. Third, most studies were conducted in Western countries, limiting the generalizability of the findings.
5 Conclusion
In summary, this scoping review mapped clinical paradigms in studies on CHR-P and BPD, revealing heterogeneous conceptualizations of clinical care, preventive and research paradigms. No clear therapeutic modalities are available for people presenting with both CHR-P and BPD. Our research recommendations can be helpful to improve cooperation and knowledge integration among preventive approaches and generate evidence with real-world clinical implications.
Data availability statement
The original contributions presented in the study are included in the article/Supplementary material, further inquiries can be directed to the corresponding author.
Author contributions
GLB: Writing – review & editing, Writing – original draft, Project administration, Methodology, Data curation, Conceptualization. TB: Writing – review & editing, Methodology, Conceptualization. AP: Writing – review & editing, Conceptualization. FF: Writing – review & editing, Data curation. BN: Writing – review & editing. MS: Writing – review & editing, Methodology. VL: Writing – review & editing, Supervision. AT: Writing – review & editing, Supervision, Methodology, Conceptualization.
Funding
The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This open access of this research was supported by funding from the Ministry of University and Research under the call Progetti di Rilevante Interesse Nazionale (PRIN) 2022 (project number 20224SX547; Principal Investigator: Giacomo Ciocca; Associated Investigator: TB) awarded to Giacomo Ciocca and TB.
Acknowledgments
The authors thank Eleonora Riccioli for her collaboration in screening the articles.
Conflict of interest
MS received honoraria/has been a consultant for AbbVie, Angelini, Lundbeck, Otsuka.
The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fpsyg.2024.1381864/full#supplementary-material
References
Aceituno, D., Vera, N., Prina, A. M., and McCrone, P. (2019). Cost-effectiveness of early intervention in psychosis: systematic review. Br. J. Psychiatry 215, 388–394. doi: 10.1192/bjp.2018.298
Agius, M., Zaman, R., and Hanafy, D. (2013). An audit to assess the consequences of the use of a pluripotential risk syndrome: the case to move on from "psychosis risk syndrome (PRS) ". Psychiatr. Danub. 25, S282–S285,
Ajnakina, O., David, A. S., and Murray, R. M. (2019). ‘At risk mental state’ clinics for psychosis—an idea whose time has come—and gone! Psychol. Med. 49, 529–534. doi: 10.1017/S0033291718003859
Altuncu, K. A., Schiano Lomoriello, A., Lo Buglio, G., Martino, L., Yenihayat, A., Belfiore, M. T., et al. (2023). Mental health literacy about personality disorders: a multicultural study. Behav. Sci. 13:605. doi: 10.3390/bs13070605
American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorders. 4th Edn. Washington, DC: American Psychiatric Association.
American Psychiatric Association (2000). Diagnostic and statistical manual of mental disorders, 4th edition, text revision (DSM-IV-TR). American Psychiatric Association. Available at: https://books.google.it/books?id=_w5-BgAAQBAJ
American Psychiatric Association (2013). Diagnostic and statistical manual of mental disorders. 5th Edn. Arlington: American Psychiatric Association.
American Psychiatric Association (2022). Diagnostic and statistical manual of mental disorders, fifth edition, text revision (DSM-5-TR).
Bargiota, S. I., Papakonstantinou, A. V., and Christodoulou, N. G. (2023). Oxytocin as a treatment for high-risk psychosis or early stages of psychosis: a mini review. Front. Psych. 14:1232776. doi: 10.3389/fpsyt.2023.1232776
Barrantes-Vidal, N., Dominguez-Martinez, T., Cristobal, P., Sheinbaum, T., Kwapil, T. R., and Barrantes-Vidal, N. (2014). Gender differences in the effect of childhood trauma experiences on prodromal symptoms and personality disorder traits in young adults at high-risk for psychosis. Schizophr. Res. 153, S89–S90. doi: 10.1016/S0920-9964(14)70284-1
Beck, K., Andreou, C., Studerus, E., Heitz, U., Ittig, S., Leanza, L., et al. (2019). Clinical and functional long-term outcome of patients at clinical high risk (CHR) for psychosis without transition to psychosis: a systematic review. Schizophr. Res. 210, 39–47. doi: 10.1016/j.schres.2018.12.047
Bertolote, J., and McGorry, P. (2005). Early intervention and recovery for young people with early psychosis: consensus statement. Br. J. Psychiatry 187, s116–s119. doi: 10.1192/bjp.187.48.s116
Biancalani, A., Pelizza, L., and Menchetti, M. (2023). Borderline personality disorder and early psychosis: a narrative review. Ann. General Psychiatry 22:44. doi: 10.1186/s12991-023-00475-w
Bohus, M., Kleindienst, N., Limberger, M. F., Stieglitz, R.-D., Domsalla, M., Chapman, A. L., et al. (2009). The short version of the borderline symptom list (BSL-23): development and initial data on psychometric properties. Psychopathology 42, 32–39. doi: 10.1159/000173701
Boldrini, T., Pontillo, M., Tanzilli, A., Giovanardi, G., Di Cicilia, G., Salcuni, S., et al. (2020a). An attachment perspective on the risk for psychosis: clinical correlates and the predictive value of attachment patterns and mentalization. Schizophr. Res. 222, 209–217. doi: 10.1016/j.schres.2020.05.052
Boldrini, T., Tanzilli, A., Di Cicilia, G., Gualco, I., Lingiardi, V., Salcuni, S., et al. (2020b). Personality traits and disorders in adolescents at clinical high risk for psychosis: toward a clinically meaningful diagnosis. Front. Psych. 11:562835. doi: 10.3389/fpsyt.2020.562835
Boldrini, T., Tanzilli, A., Pontillo, M., Chirumbolo, A., Vicari, S., and Lingiardi, V. (2019). Comorbid personality disorders in individuals with an at-risk mental state for psychosis: a meta-analytic review. Front. Psych. 10:429. doi: 10.3389/fpsyt.2019.00429
Bolhuis, K., Lång, U., Gyllenberg, D., Kääriälä, A., Veijola, J., Gissler, M., et al. (2021). Hospital presentation for self-harm in youth as a risk marker for later psychotic and bipolar disorders: a cohort study of 59 476 Finns. Schizophr. Bull. 47, 1685–1694. doi: 10.1093/schbul/sbab061
Borsboom, D., Deserno, M. K., Rhemtulla, M., Epskamp, S., Fried, E. I., McNally, R. J., et al. (2021). Network analysis of multivariate data in psychological science. Nat. Rev. Meth. Primers 1, 1–18. doi: 10.1038/s43586-021-00055-w
Burke, T., Thompson, A., Mifsud, N., Yung, A. R., Nelson, B., McGorry, P., et al. (2022). Proportion and characteristics of young people in a first-episode psychosis clinic who first attended an at-risk mental state service or other specialist youth mental health service. Schizophr. Res. 241, 94–101. doi: 10.1016/j.schres.2021.12.035
Byars, K. R. (2013). The effects of personality disorder traits on individual therapy outcomes in individuals at clinical high risk for schizophrenia. Available at: https://www.proquest.com/docview/1467473545?parentSessionId=gTfJv9IsVXO6LAXSZd1Anj7szTQUJ%2BaGMS4tXCHbtGw%3D
Catalan, A., Salazar de Pablo, G., Vaquerizo Serrano, J., Mosillo, P., Baldwin, H., Fernández-Rivas, A., et al. (2021). Annual research review: prevention of psychosis in adolescents – systematic review and meta-analysis of advances in detection, prognosis and intervention. J. Child Psychol. Psychiatry 62, 657–673. doi: 10.1111/jcpp.13322
Cavelti, M., Thompson, K., Chanen, A. M., and Kaess, M. (2021). Psychotic symptoms in borderline personality disorder: developmental aspects. Curr. Opin. Psychol. 37, 26–31. doi: 10.1016/j.copsyc.2020.07.003
Ceccolini, C. J., Green, J. B., and Friedman-Yakoobian, M. S. (2023). Gender-affirming care in the assessment and treatment of psychosis risk: considering minority stress in current practice and future research. Early Interv. Psychiatry. 18, 207–216. doi: 10.1111/eip.13456
Chanen, A. (2017). Borderline personality disorder is not a variant of normal adolescent development. Personal. Ment. Health 11, 147–149. doi: 10.1002/pmh.1392
Chanen, A. M., McCutcheon, L. K., Germano, D., Nistico, H., Jackson, H. J., and McGorry, P. D. (2009). The HYPE clinic: an early intervention service for borderline personality disorder. J. Psychiatr. Pract. 15, 163–172. doi: 10.1097/01.pra.0000351876.51098.f0
Chanen, A. M., Sharp, C., and Hoffman, P. (2017). Prevention and early intervention for borderline personality disorder: a novel public health priority. World Psychiatry 16, 215–216. doi: 10.1002/WPS.20429
Chanen, A. M., and Thompson, K. N. (2018). Early intervention for personality disorder. Curr. Opin. Psychol. 21, 132–135. doi: 10.1016/j.copsyc.2018.02.012
DaBreo-Otero, C . (2021). The course of axis I and axis II disorders in clinical high risk (CHR) adolescents. Available at: https://www.proquest.com/docview/2568003794
DeFife, J. A., Malone, J. C., DiLallo, J., and Westen, D. (2013). Assessing adolescent personality disorders with the Shedler–Westen assessment procedure for adolescents. Clin. Psychol. Sci. Pract. 20, 393–407. doi: 10.1037/h0101720
Destrée, L., Albertella, L., Jobson, L., McGorry, P., Chanen, A., Ratheesh, A., et al. (2023). The association between stressful experiences and OCD symptoms in young adults at transdiagnostic risk. J. Affect. Disord. 328, 128–134. doi: 10.1016/j.jad.2023.02.059
Fagioli, F., Telesforo, L., Dell'Erba, A., Consolazione, M., Migliorini, V., Patanè, M., et al. (2015). Depersonalization: An exploratory factor analysis of the Italian version of the Cambridge Depersonalization Scale. Comprehensive psychiatry. 60, 161–167. doi: 10.1016/j.comppsych.2014.06.007
First, M. B., Gibbon, M., Spitzer, R. L., Williams, J. B. W., and Benjamin, L. S. (1997). Structured clinical interview for DSM-IV Axis II personality disorders (SCID-II). Washington, DC: American Psychiatric Press, Inc.
First, M. B., Williams, J. B. W., and Benjamin, L. (2016). Structured clinical interview for DSM-5 personality disorders (SCID-5-PD). Washington, DC: American Psychiatric Publishing.
Fornaro, M., De Prisco, M., Billeci, M., Ermini, E., Young, A. H., Lafer, B., et al. (2021). Implications of the COVID-19 pandemic for people with bipolar disorders: a scoping review. J. Affect. Disord. 295, 740–751. doi: 10.1016/j.jad.2021.08.091
Fusar-Poli, P., Correll, C. U., Arango, C., Berk, M., Patel, V., and Ioannidis, J. P. A. (2021). Preventive psychiatry: a blueprint for improving the mental health of young people. World Psychiatry 20, 200–221. doi: 10.1002/wps.20869
Fusar-Poli, P., Estradé, A., Stanghellini, G., Venables, J., Onwumere, J., Messas, G., et al. (2022). The lived experience of psychosis: a bottom-up review co-written by experts by experience and academics. World Psychiatry 21, 168–188. doi: 10.1002/wps.20959
Fusar-Poli, P., Rutigliano, G., Stahl, D., Davies, C., De Micheli, A., Ramella-Cravaro, V., et al. (2017). Long-term validity of the at risk mental state (ARMS) for predicting psychotic and non-psychotic mental disorders. Eur. Psychiatry 42, 49–54. doi: 10.1016/j.eurpsy.2016.11.010
Fusar-Poli, P., Salazar de Pablo, G., Correll, C. U., Meyer-Lindenberg, A., Millan, M. J., Borgwardt, S., et al. (2020a). Prevention of psychosis: advances in detection, prognosis, and intervention. JAMA Psychiatry 77, 755–765. doi: 10.1001/jamapsychiatry.2019.4779
Fusar-Poli, P., Salazar de Pablo, G., De Micheli, A., Nieman, D. H., Correll, C. U., Kessing, L. V., et al. (2020b). What is good mental health? A scoping review. Eur. Neuropsychopharmacol. 31, 33–46. doi: 10.1016/j.euroneuro.2019.12.105
Gajwani, R., Wilson, N., Nelson, R., Gumley, A., Smith, M., and Minnis, H. (2022). Recruiting and exploring vulnerabilities among young people at risk, or in the early stages of serious mental illness (borderline personality disorder and first episode psychosis). Front. Psych. 13:943509. doi: 10.3389/fpsyt.2022.943509
Gerstenberg, M., Hauser, M., Al-Jadiri, A., Sheridan, E. M., Kishimoto, T., Borenstein, Y., et al. (2015). Frequency and correlates of DSM-5 attenuated psychosis syndrome in a sample of adolescent inpatients with nonpsychotic psychiatric disorders. J. Clin. Psychiatry 76, e1449–e1458. doi: 10.4088/JCP.14m09435
Gruber, M., Alexopoulos, J., Doering, S., Feichtinger, K., Friedrich, F., Klauser, M., et al. (2023). Personality functioning and self-disorders in individuals at ultra-high risk for psychosis, with first-episode psychosis and with borderline personality disorder. BJPsych Open 9:e150. doi: 10.1192/bjo.2023.530
Hadar, H., Zhang, H., Phillips, L. J., Amminger, G. P., Berger, G. E., Chen, E. Y. H., et al. (2020). Do schizotypal or borderline personality disorders predict onset of psychotic disorder or persistent attenuated psychotic symptoms in patients at high clinical risk? Schizophr. Res. 220, 275–277. doi: 10.1016/j.schres.2020.03.065
Hartmann, J. A., McGorry, P. D., Destree, L., Amminger, G. P., Chanen, A. M., Davey, C. G., et al. (2021). Pluripotential risk and clinical staging: theoretical considerations and preliminary data from a Transdiagnostic risk identification approach. Front. Psych. 11:553578. doi: 10.3389/fpsyt.2020.553578
Henriksen, M. G., Raballo, A., and Nordgaard, J. (2021). Self-disorders and psychopathology: a systematic review. Lancet Psychiatry 8, 1001–1012. doi: 10.1016/s2215-0366(21)00097-3
Howes, O. D., Whitehurst, T., Shatalina, E., Townsend, L., Onwordi, E. C., Mak, T. L. A., et al. (2021). The clinical significance of duration of untreated psychosis: an umbrella review and random-effects meta-analysis. World Psychiatry 20, 75–95. doi: 10.1002/wps.20822
Jorm, A. F. (2000). Mental health literacy: public knowledge and beliefs about mental disorders. Br. J. Psychiatry 177, 396–401. doi: 10.1192/bjp.177.5.396
Jorm, A. F., Christensen, H., and Griffiths, K. M. (2006). The public’s ability to recognize mental disorders and their beliefs about treatment: changes in Australia over 8 years. Aust. N. Z. J. Psychiatry 40, 36–41. doi: 10.1111/j.1440-1614.2006.01738.x
Khalil, H., Peters, M. D., Tricco, A. C., Pollock, D., Alexander, L., McInerney, P., et al. (2021). Conducting high quality scoping reviews-challenges and solutions. J. Clin. Epidemiol. 130, 156–160. doi: 10.1016/j.jclinepi.2020.10.009
Kotlicka-Antczak, M., Pawelczyk, T., Podgorski, M., Zurner, N., Karbownik, M. S., and Pawelczyk, A. (2018). Polish individuals with an at-risk mental state: demographic and clinical characteristics. Early Interv. Psychiatry 12, 391–399. doi: 10.1111/eip.12333
Koutsouleris, N., Davatzikos, C., Borgwardt, S., Gaser, C., Bottlender, R., Frodl, T., et al. (2014). Accelerated brain aging in schizophrenia and beyond: a neuroanatomical marker of psychiatric disorders. Schizophr. Bull. 40, 1140–1153. doi: 10.1093/schbul/sbt142
Lingiardi, V., and Boldrini, T. (2019). The Diagnostic Dilemma of Psychosis: Reviewing the Historical Case of Pseudoneurotic Schizophrenia. The Journal of nervous and mental disease. 207, 577–584. doi: 10.1097/NMD.0000000000001008
Lo Buglio, G., Pontillo, M., Cerasti, E., Polari, A., Schiano Lomoriello, A., Vicari, S., et al. (2022). A network analysis of anxiety, depressive, and psychotic symptoms and functioning in children and adolescents at clinical high risk for psychosis. Front. Psych. 13:1016154. doi: 10.3389/fpsyt.2022.1016154
Madsen, H. K., Nordholm, D., Krakauer, K., Randers, L., and Nordentoft, M. (2018). Psychopathology and social functioning of 42 subjects from a Danish ultra high-risk cohort. Early Interv. Psychiatry 12, 1181–1187. doi: 10.1111/eip.12438
Marshall, M., Lewis, S., Lockwood, A., Drake, R., Jones, P., and Croudace, T. (2005). Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch. Gen. Psychiatry 62, 975–983. doi: 10.1001/archpsyc.62.9.975
Maurer, K., Zink, M., Rausch, F., and Haefner, H. (2018). The early recognition inventory ERIraos assesses the entire spectrum of symptoms through the course of an at-risk mental state. Early Interv. Psychiatry 12, 217–228. doi: 10.1111/eip.12305
McGorry, P. D., Mei, C., Chanen, A., Hodges, C., Alvarez-Jimenez, M., and Killackey, E. (2022). Designing and scaling up integrated youth mental health care. World Psychiatry 21, 61–76. doi: 10.1002/wps.20938
McMillan, E., Sanchez, A. A., Bhaduri, A., Pehlivan, N., Monson, K., Badcock, P., et al. (2017). Sexual functioning and experiences in young people affected by mental health disorders. Psychiatry Res. 253, 249–255. doi: 10.1016/j.psychres.2017.04.009
Miller, T. J., McGlashan, T. H., Rosen, J. L., Cadenhead, K., Ventura, J., McFarlane, W., et al. (2003). Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr. Bull. 29, 703–715. doi: 10.1093/oxfordjournals.schbul.a007040
Monego, E., Cremonese, C., Gentili, F., Fusar-Poli, P., Shah, J. L., and Solmi, M. (2022). Clinical high at-risk mental state in young subjects accessing a mental disorder prevention service in Italy. Psychiatry Res. 316, 114710. doi: 10.1016/j.psychres.2022.114710
Nelson, B., McGorry, P. D., Wichers, M., Wigman, J. T. W., and Hartmann, J. A. (2017). Moving from static to dynamic models of the onset of mental disorder a review. JAMA Psychiatry 74, 528–534. doi: 10.1001/jamapsychiatry.2017.0001
Nelson, B., Thompson, A., Chanen, A. M., Amminger, G. P., and Yung, A. R. (2013). Is basic self-disturbance in ultra-high risk for psychosis (' ‘prodromal’) patients associated with borderline personality pathology? Early Interv. Psychiatry 7, 306–310. doi: 10.1111/eip.12011
NICE (2009). Borderline personality disorder: recognition and management. CG78. Available at: https://www.nice.org.uk/guidance/cg78 (Accessed August 12, 2023).
NICE (2014). Psychosis and schizophrenia in adults: Prevention and management. Nice. Available at: (https://www.nice.org.uk/guidance/cg178).
Nordgaard, J., Nielsen, K. M., Rasmussen, A. R., and Henriksen, M. G. (2023). Psychiatric comorbidity: a concept in need of a theory. Psychol. Med. 53, 5902–5908. doi: 10.1017/S0033291723001605
O’Connor, K., Nelson, B., Cannon, M., Yung, A., and Thompson, A. (2019). Perceptual abnormalities in an ultra-high risk for psychosis population relationship to trauma and co-morbid disorder. Early Interv. Psychiatry 13, 231–240. doi: 10.1111/eip.12469
Ong, H. L., Isvoranu, A. M., Schirmbeck, F., McGuire, P., Valmaggia, L., Kempton, M. J., et al. (2021). Obsessive-compulsive symptoms and other symptoms of the at-risk mental state for psychosis: a network perspective. Schizophr. Bull. 47, 1018–1028. doi: 10.1093/schbul/sbaa187
Osório, F. L., Loureiro, S. R., Hallak, J. E. C., Machado-de-Sousa, J. P., Ushirohira, J. M., Baes, C. V. W., et al. (2019). Clinical validity and intrarater and test–retest reliability of the structured clinical interview for DSM-5–clinician version (SCID-5-CV). Psychiatry Clin. Neurosci. 73, 754–760. doi: 10.1111/pcn.12931
Paust, T., Theodoridou, A., Mueller, M., Wyss, C., Obermann, C., Roessler, W., et al. (2019). Borderline personality pathology in an at risk mental state sample. Front. Psych. 10, 838. doi: 10.3389/fpsyt.2019.00838
Pelizza, L., Leuci, E., Quattrone, E., Paulillo, G., and Pellegrini, P. (2023). The “Parma at-risk mental states” (PARMS) program: general description and process analysis after 5 years of clinical activity. Early Interv. Psychiatry. 17, 625–635.doi: 10.1111/eip.13399
Peters, M. D. J., Godfrey, C. M., Khalil, H., McInerney, P., Parker, D., and Soares, C. B. (2015). Guidance for conducting systematic scoping reviews. Int. J. Evid. Based Healthc. 13, 141–146. doi: 10.1097/XEB.0000000000000050
Peters, M. D. J., Godfrey, C., McInerney, P., Munn, Z., Tricco, A. C., and Khalil, H. (2020). “Chapter 11: scoping reviews (2020 version)” in JBI manual for evidence synthesis. Eds. Aromataris, E., Munn, Z., 406–451.
Peters, M. D. J., Marnie, C., Tricco, A. C., Pollock, D., Munn, Z., Alexander, L., et al. (2020). Updated methodological guidance for the conduct of scoping reviews. JBI Evid Synth 18, 2119–2126. doi: 10.11124/JBIES-20-00167
Pfohl, B., Blum, N., and Zimmerman, M. (1997). Structured interview for DSM-IV personality: Sidp-IV. Washington, DC: American Psychiatric Pub.
Reininghaus, U., Paetzold, I., Rauschenberg, C., Hirjak, D., Banaschewski, T., Meyer-Lindenberg, A., et al. (2023). Effects of a novel, Transdiagnostic ecological momentary intervention for prevention, and early intervention of severe mental disorder in youth (EMIcompass): findings from an exploratory randomized controlled trial. Schizophr. Bull. 49, 592–604. doi: 10.1093/schbul/sbac212
Rutigliano, G., Valmaggia, L., Landi, P., Frascarelli, M., Cappucciati, M., Sear, V., et al. (2016). Persistence or recurrence of non-psychotic comorbid mental disorders associated with 6-year poor functional outcomes in patients at ultra high risk for psychosis. J. Affect. Disord. 203, 101–110. doi: 10.1016/j.jad.2016.05.053
Ryan, J., Graham, A., Nelson, B., and Yung, A. (2017). Borderline personality pathology in young people at ultra high risk of developing a psychotic disorder. Early Interv. Psychiatry 11, 208–214. doi: 10.1111/eip.12236
Salazar de Pablo, G., Catalan, A., and Fusar-Poli, P. (2020a). Clinical validity of DSM-5 attenuated psychosis syndrome: advances in diagnosis, prognosis, and treatment. JAMA Psychiatry 77, 311–320. doi: 10.1001/jamapsychiatry.2019.3561
Salazar de Pablo, G., Estradé, A., Cutroni, M., Andlauer, O., and Fusar-Poli, P. (2021a). Establishing a clinical service to prevent psychosis: what, how and when? Systematic review. Transl. Psychiatry 11:43. doi: 10.1038/s41398-020-01165-x
Salazar de Pablo, G., Guinart, D., Cornblatt, B. A., Auther, A. M., Carrión, R. E., Carbon, M., et al. (2020b). DSM-5 attenuated psychosis syndrome in adolescents hospitalized with non-psychotic psychiatric disorders. Front. Psych. 11:568982. doi: 10.3389/fpsyt.2020.568982
Salazar de Pablo, G., Radua, J., Pereira, J., Bonoldi, I., Arienti, V., Besana, F., et al. (2021b). Probability of transition to psychosis in individuals at clinical high risk an updated Meta-analysis. JAMA Psychiatry 78, 970–978. doi: 10.1001/jamapsychiatry.2021.0830
Sanchez, A. Y. A., McMillan, E., Bhaduri, A., Pehlivan, N., Monson, K., Badcock, P., et al. (2019). High-risk sexual behaviour in young people with mental health disorders. Early Interv. Psychiatry 13, 867–873. doi: 10.1111/eip.12688
Schmidt, S. J., Schultze-Lutter, F., Schimmelmann, B. G., Maric, N. P., Salokangas, R. K. R., Riecher-Rössler, A., et al. (2015). EPA guidance on the early intervention in clinical high risk states of psychoses. Eur. Psychiatry 30, 388–404. doi: 10.1016/j.eurpsy.2015.01.013
Schultze-Lutter, F., Addington, J., Ruhrmann, S., and Klosterko¨tter, J. (2007). Schizophrenia Proneness Instrument, Adult Version (SPI-A). Rome. Italy: Giovanni Fiorito Editore.
Schultze-Lutter, F., Klosterkötter, J., Michel, C., Winkler, K., and Ruhrmann, S. (2012). Personality disorders and accentuations in at-risk persons with and without conversion to first-episode psychosis. Early Interv. Psychiatry 6, 389–398. doi: 10.1111/j.1751-7893.2011.00324.x
Seiler, N., Maguire, J., Nguyen, T., Sizer, H., McGorry, P., Nelson, B., et al. (2020). Prevalence of subthreshold positive symptoms in young people without psychotic disorders presenting to a youth mental health service. Schizophr. Res. 215, 446–448. doi: 10.1016/j.schres.2019.10.041
Sevilla-Llewellyn-Jones, J., Camino, G., Russo, D. A., Painter, M., Montejo, A. L., Ochoa, S., et al. (2018). Clinically significant personality traits in individuals at high risk of developing psychosis. Psychiatry Res. 261, 498–503. doi: 10.1016/j.psychres.2018.01.027
Shah, J. L., Scott, J., McGorry, P. D., Cross, S. P. M., Keshavan, M. S., Nelson, B., et al. (2020). Transdiagnostic clinical staging in youth mental health: a first international consensus statement. World Psychiatry 19, 233–242. doi: 10.1002/wps.20745
Simonsen, S., Bateman, A., Bohus, M., Dalewijk, H. J., Doering, S., Kaera, A., et al. (2019). European guidelines for personality disorders: past, present and future. Borderline Personal Disord. Emot. Dysregul. 6:9. doi: 10.1186/s40479-019-0106-3
Solmi, M., Radua, J., Olivola, M., Croce, E., Soardo, L., Salazar de Pablo, G., et al. (2022). Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies. Mol. Psychiatry 28, 2291–2300. doi: 10.1038/s41380-021-01161-7
Solmi, M., Rocca, F. D., Cianci, V., Giacometti, A., Alexopulos, C., Granziol, U., et al. (2020). Emergency department and early detection of adolescents and young adults at risk of developing mental disorders: an exploratory study. Res. Psychother. 23:459. doi: 10.4081/ripppo.2020.459
Solmi, M., Soardo, L., Kaur, S., Azis, M., Cabras, A., Censori, M., et al. (2023). Meta-analytic prevalence of comorbid mental disorders in individuals at clinical high risk of psychosis: the case for transdiagnostic assessment. Mol. Psychiatry. doi: 10.1038/s41380-023-02029-8
The Public Health Group (2005). The Victorian burden of disease study. Victorian Government Department of Human Services.
Thompson, A., Nelson, B., Bechdolf, A., Chanen, A. M., Domingues, I., McDougall, E., et al. (2012). Borderline personality features and development of psychosis in an `ultra high risk’ (UHR) population: a case control study. Early Interv. Psychiatry 6, 247–255. doi: 10.1111/j.1751-7893.2012.00365.x
Tricco, A. C., Lillie, E., Zarin, W., O’Brien, K. K., Colquhoun, H., Levac, D., et al. (2018). PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann. Intern. Med. 169, 467–473. doi: 10.7326/M18-0850
Tronick, L. N., Mirzakhanian, H., Addington, J., Bearden, C. E., Cannon, T. D., Cornblatt, B. A., et al. (2023). Risk of violent behaviour in young people at clinical high risk for psychosis from the north American Prodrome longitudinal studies consortium. Early Interv. Psychiatry. 17, 759–770. doi: 10.1111/eip.13369
Uhlhaas, P. J., Davey, C. G., Mehta, U. M., Shah, J., Torous, J., Allen, N. B., et al. (2023). Towards a youth mental health paradigm: a perspective and roadmap. Mol Psychiatry. 28, 3171–3181. doi: 10.1038/s41380-023-02202-z
West, M. L., Guest, R. M., and Carmel, A. (2021). Comorbid early psychosis and borderline personality disorder: conceptualizing clinical overlap, etiology, and treatment. Personal. Ment. Health 15, 208–222. doi: 10.1002/pmh.1509
West, M. L., Guest, R. M., Carmel, A., Madigan, R., and Yen, S. (2022). Borderline personality features among individuals at clinical high risk for psychosis (CHR-P): a brief report. Early Interv. Psychiatry 17, 223–228. doi: 10.1111/eip.13336
Westen, D., Dutra, L., and Shedler, J. (2005). Assessing adolescent personality pathology. Br. J. Psychiatry 186, 227–238. doi: 10.1192/bjp.186.3.227
World Health Organization (1992). The ICD-10 classification of mental and behavioural disorders: Clinical descriptions and diagnostic guidelines. Geneva: World Health Organization.
World Health Organization. (2022). World mental health report: Transforming mental health for all. Geneva:WHO. Available at: https://www.who.int/publications/i/item/9789240049338 (Accessed September 13, 2023).
Woschnik, M., and Herpertz, S. (1994). Selbstbeurteilung nach der Aachener Merkmalsliste für Persönlichkeitsstörungen [Selfassessment version of the Aachen checklist of personality disorders]. Aachen : Psychiatric Department of the RWTH Aachen .
Yung, A. R., McGorry, P. D., Francey, S. M., Nelson, B., Baker, K., Phillips, L. J., et al. (2007). PACE: a specialised service for young people at risk of psychotic disorders. Med. J. Aust. 187, S43–S46. doi: 10.5694/j.1326-5377.2007.tb01336.x
Yung, A. R., Yung, A. R., Pan Yuen, H., Mcgorry, P. D., Phillips, L. J., Kelly, D., et al. (2005). Mapping the onset of psychosis: the comprehensive assessment of at-risk mental states. Austr. New Zealand J. Psychiatr. 39, 964–971. doi: 10.1080/j.1440-1614.2005.01714.x
Zandersen, M., Henriksen, M. G., and Parnas, J. (2019). A recurrent question: what is borderline? J. Personal. Disord. 33, 341–369. doi: 10.1521/pedi_2018_32_348
Zandersen, M., and Parnas, J. (2019). Identity disturbance, feelings of emptiness, and the boundaries of the schizophrenia Spectrum. Schizophr. Bull. 45, 106–113. doi: 10.1093/schbul/sbx183
Keywords: clinical high risk for psychosis, borderline personality disorder, comorbidity, psychosis, early intervention, transdiagnostic approach, scoping review
Citation: Lo Buglio G, Boldrini T, Polari A, Fiorentino F, Nelson B, Solmi M, Lingiardi V and Tanzilli A (2024) Harmonizing early intervention strategies: scoping review of clinical high risk for psychosis and borderline personality disorder. Front. Psychol. 15:1381864. doi: 10.3389/fpsyg.2024.1381864
Edited by:
Yicheng Long, Central South University, ChinaReviewed by:
Stavroula Bargiota, University of Thessaly, GreeceAnna Papakonstantinou, Aristotle University of Thessaloniki, Greece
Copyright © 2024 Lo Buglio, Boldrini, Polari, Fiorentino, Nelson, Solmi, Lingiardi and Tanzilli. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Tommaso Boldrini, tommaso.boldrini@unipegaso.it
†These authors have contributed equally to this work and share last authorship
‡ORCID: Gabriele Lo Buglio, orcid.org/0000-0003-2425-8383
Tommaso Boldrini, orcid.org/0000-0003-3381-9445
Andrea Polari, orcid.org/0000-0002-0680-3192
Flavia Fiorentino, orcid.org/0009-0002-5954-1736
Barnaby Nelson, orcid.org/0000-0002-6263-2332
Marco Solmi, orcid.org/0000-0003-4877-7233
Vittorio Lingiardi, orcid.org/0000-0002-1298-3935
Annalisa Tanzilli, orcid.org/0000-0002-6098-2304